Purchase Order 75D30126P20816

The Centers for Disease Control and Prevention's Pittsburgh facility awarded Luminex Corporation a definitive firm fixed-price contract on August 19, 2024, valued at approximately $249K, with a completion date of December 30, 2024. Under the GHC major program code, this contract procures multiplex analyte detection instruments that do not require laser technology, thereby reducing calibration frequency and associated costs compared to laser-dependent systems. CDC has utilized these same...

The Centers for Disease Control and Prevention (CDC) awarded Luminex Corporation a $101,651.60 purchase order contract for laboratory supplies. The contract has a period of performance from September 21, 2023 through November 1, 2024. Luminex will provide the supplies to support CDC programs in Pittsburgh, Pennsylvania on a firm fixed price basis. No subcontractors or set aside designations were identified. The CDC works to protect public health and safety through the control and prevention of...

This is a $7,717 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Luminex Corporation, a manufacturer of biological testing technologies. The contract is for the provision of a LUMINEX 200 service and does not have a set-aside designation. Luminex often serves as a prime contractor delivering specialized multiplexing systems that support clinical testing programs and biomedical research efforts across federal agencies,...

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $20,700 firm fixed price delivery order against the Multiple Award Schedule to Luminex Corporation for the purchase of laboratory equipment. The award, made on February 19, 2020, does not have a set-aside designation and calls for delivery of the equipment by May 18, 2020. Luminex will provide the equipment to the CDC from its place of performance in Austin, Texas to support the agency's...

The Centers for Disease Control and Prevention (CDC) awarded a $77,468.82 firm fixed price purchase order to Luminex Corporation for MAGPIX and reagent lab supplies. The CDC, located within the Department of Health and Human Services, will utilize these products to support its infectious disease prevention and control programs conducted from its Pittsburgh location. Luminex will deliver the requested supplies from its production facilities in Austin, Texas by October 27, 2023 to meet the CDC's...

The Centers for Disease Control and Prevention's Division of HIV/AIDS Prevention, located in Pittsburgh, awarded a $30,250 firm fixed-price purchase order to Luminex Corporation on July 31, 2024, with a completion date of September 30, 2024. This contract procures a Luminex MAGPIX instrument, an automated multiplex diagnostic platform that has been extensively utilized by the Immunology Laboratory Branch's serology and incidence team for HIV recency testing projects. The MAGPIX has previously...

This federal contract award is for a LUMINEX GUAVA SYSTEM, valued at $94,312.30, and was issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA. The contract was awarded to Luminex Corporation, a manufacturer of biological testing technologies, including multiplex diagnostic solutions for clinical laboratories and life science research settings. The contract is a firm fixed-price purchase order and is not a set-aside. Luminex has provided various diagnostic testing...

This $55,458.60 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies, to provide laboratory supplies. The contract does not have a set-aside designation. Luminex has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health, to deliver immunology...

This is a $20,791.54 firm-fixed price purchase order awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract is for the delivery of MICROSPHERE, MAGPLEXAVIDIN, REG 026, 1ML to the Centers for Disease Control and Prevention (CDC) in Pittsburgh. The contract has a completion date of September 30, 2024 and was awarded on September 12, 2024. There is no set-aside designation for this award. Luminex has provided various diagnostic testing...

This is a $23,850 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the provision of LUMINEX 200 SERVICE, with a period of performance through July 2027. Luminex Corporation is the prime contractor and holds several significant federal contract vehicles with the USDA and Department of Veterans Affairs for its specialized...